Target Name: LOC107987304
NCBI ID: G107987304
Review Report on LOC107987304 Target / Biomarker Content of Review Report on LOC107987304 Target / Biomarker
LOC107987304
Other Name(s): Uncharacterized LOC107987304

LOC107987304: A Novel Protein Target for Drug Development

LOC107987304 is a novel protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function make it an attractive target for researchers to study and develop new treatments.

The protein LOC107987304 is a member of the LOC107987 family, which is characterized by a unique topology of the amino acid residues. This topology, which is composed of a combination of beta-helices and alpha-helices, gives LOC107987304 a unique 3D structure that is distinct from other proteins.

LOC107987304 has been shown to play a role in various physiological processes, including cell signaling, inflammation, and stress response. It is expressed in a variety of tissues and cells, including brain, muscle, and immune cells.

One of the most promising aspects of LOC107987304 is its potential as a drug target. The unique structure of the protein makes it difficult to predict the binding sites and potential interactions with small molecules. This, in turn, creates a high degree of uncertainty and makes it difficult to design small molecules that can interact with LOC107987304 specifically.

However, researchers have identified a number of potential binding sites on the protein that could be targeted by small molecules. These sites are located in the regions of the protein that are most conserved and have been shown to play important roles in various physiological processes.

One of the most promising binding sites is located in the N-terminus of the protein, which is known as the region that is most exposed to the cell membrane. This region has been shown to be involved in various signaling pathways, including the production of reactive oxygen species (ROS) and the regulation of inflammation. Therefore, small molecules that can interact with this region may have a unique mechanism of action.

Another potential binding site is located in the middle of the protein, which is known as the alpha-helices region. This region is known for its role in various cellular processes, including cell signaling and protein-protein interactions. Therefore, small molecules that can interact with this region may have a unique mechanism of action.

LOC107987304 has also been shown to play a role in various stress responses, including the regulation of inflammation and the response to oxidative stress. Therefore, small molecules that can interact with this region may have a unique mechanism of action.

In conclusion, LOC107987304 is a novel protein that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and function make it an attractive target for researchers to study and develop new treatments. While more research is needed to fully understand its mechanisms of action and potential as a drug, its potential as a potential drug target and biomarker is an exciting area of research.

Protein Name: Uncharacterized LOC107987304

The "LOC107987304 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107987304 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512 | LOC343052 | LOC344967